Select Your Region
Americas
Europe
Africa
Global
Find participating medical centers and current study status in each of them
Find participating medical centers
-
Home
-
Clinical Study Finder
- HAVEN 3
A Clinical Trial to Evaluate Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors (HAVEN3)
A Clinical Trial to Evaluate Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants Without Inhibitors
Hemophilia Hemophilia A
Study results
LPS_BH30071_HAVEN3_interim results_January2021_Afrikaans_South Africa
(PDF, 1.2 MB)
LPS_BH30071_HAVEN3_interim results_January2021_Chinese_Taiwan
(PDF, 0.9 MB)
LPS_BH30071_HAVEN3_interim results_January2021_German
(PDF, 0.6 MB)
LPS_BH30071_HAVEN3_interim results_January2021_Italian
(PDF, 0.8 MB)
LPS_BH30071_HAVEN3_interim results_January2021_Korean
(PDF, 1.0 MB)
LPS_BH30071_HAVEN3_interim results_January2021_Polish
(PDF, 1.2 MB)
LPS_BH30071_HAVEN3_interim results_January2021_Sotho_South Africa
(PDF, 1.2 MB)
LPS_BH30071_HAVEN3_interim results_January2021_Spanish_Costa Rica
(PDF, 1.3 MB)
LPS_BH30071_HAVEN3_interim results_January2021_Spanish_Spain
(PDF, 1.2 MB)
LPS_BH30071_HAVEN3_interim results_January2021_Zulu_South Africa
(PDF, 1.2 MB)
LPS BH30071 HAVEN 3 Final Results March 2023 English
(PDF, 1.1 MB)
Explore related studies
For the latest version of this information please go to www.forpatients.roche.com